The Case For Custom Antibodies

While the world awaits a vaccine, drugmakers—and the US government—are throwing resources behind a potential stop-gap solution: custom antibodies designed to fight COVID-19.
Grown in bioreactor vats, these monoclonal antibodies are copies of naturally occurring proteins.
Already used against cancer and other disorders, the method has been endorsed by big-name scientists including Anthony Fauci, who says they are “almost a sure bet” against COVID-19.

But unlike a vaccine, the immunity provided would wane.
Drugmakers are racing to find the ideal combination of antibodies to take on COVID-19, and rival drugmakers have been cleared to join their manufacturing forces if any one drug gets the green light.

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top